Laryngeal cancer surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{OK}} | {{CMG}} {{AE}}{{OK}} | ||
==Overview== | ==Overview== | ||
The feasibility of surgery depends on the stage of laryngeal cancer at the time of diagnosis. | The feasibility of [[surgery]] depends on the stage of laryngeal cancer at the time of [[diagnosis]]. The goal of treatment is to completely remove the [[tumor]], achieve [[tumor]] free margins and prevent the spread. The options of [[surgery]] can be transoral [[laser surgery]], transoral [[robotic surgery]], total [[laryngectomy]], and total [[laryngectomy]] with partial pharyngectomy | ||
==Surgery== | ==Surgery== | ||
The goal of treatment is to completely remove the | The goal of treatment is to completely remove the [[tumor]], achieve [[tumor]] free margins and prevent the spread. The following options of [[surgery]] can be considered on a case by case basis: | ||
* Transoral [[laser surgery]] <ref name="pmid17413407">{{cite journal |vauthors=Ambrosch P |title=The role of laser microsurgery in the treatment of laryngeal cancer |journal=Curr Opin Otolaryngol Head Neck Surg |volume=15 |issue=2 |pages=82–8 |date=April 2007 |pmid=17413407 |doi=10.1097/MOO.0b013e3280147336 |url=}}</ref><ref name="pmid24970297">{{cite journal |vauthors=Zeitels SM, Burns JA |title=Oncologic efficacy of angiolytic KTP laser treatment of early glottic cancer |journal=Ann. Otol. Rhinol. Laryngol. |volume=123 |issue=12 |pages=840–6 |date=December 2014 |pmid=24970297 |doi=10.1177/0003489414538936 |url=}}</ref> | * Transoral [[laser surgery]] <ref name="pmid17413407">{{cite journal |vauthors=Ambrosch P |title=The role of laser microsurgery in the treatment of laryngeal cancer |journal=Curr Opin Otolaryngol Head Neck Surg |volume=15 |issue=2 |pages=82–8 |date=April 2007 |pmid=17413407 |doi=10.1097/MOO.0b013e3280147336 |url=}}</ref><ref name="pmid24970297">{{cite journal |vauthors=Zeitels SM, Burns JA |title=Oncologic efficacy of angiolytic KTP laser treatment of early glottic cancer |journal=Ann. Otol. Rhinol. Laryngol. |volume=123 |issue=12 |pages=840–6 |date=December 2014 |pmid=24970297 |doi=10.1177/0003489414538936 |url=}}</ref> | ||
* Transoral [[robotic surgery]] <ref name="pmid23008093">{{cite journal |vauthors=Mendelsohn AH, Remacle M, Van Der Vorst S, Bachy V, Lawson G |title=Outcomes following transoral robotic surgery: supraglottic laryngectomy |journal=Laryngoscope |volume=123 |issue=1 |pages=208–14 |date=January 2013 |pmid=23008093 |doi=10.1002/lary.23621 |url=}}</ref><ref name="pmid23918439">{{cite journal |vauthors=Lallemant B, Chambon G, Garrel R, Kacha S, Rupp D, Galy-Bernadoy C, Chapuis H, Lallemant JG, Pham HT |title=Transoral robotic surgery for the treatment of T1-T2 carcinoma of the larynx: preliminary study |journal=Laryngoscope |volume=123 |issue=10 |pages=2485–90 |date=October 2013 |pmid=23918439 |doi=10.1002/lary.23994 |url=}}</ref> | * Transoral [[robotic surgery]] <ref name="pmid23008093">{{cite journal |vauthors=Mendelsohn AH, Remacle M, Van Der Vorst S, Bachy V, Lawson G |title=Outcomes following transoral robotic surgery: supraglottic laryngectomy |journal=Laryngoscope |volume=123 |issue=1 |pages=208–14 |date=January 2013 |pmid=23008093 |doi=10.1002/lary.23621 |url=}}</ref><ref name="pmid23918439">{{cite journal |vauthors=Lallemant B, Chambon G, Garrel R, Kacha S, Rupp D, Galy-Bernadoy C, Chapuis H, Lallemant JG, Pham HT |title=Transoral robotic surgery for the treatment of T1-T2 carcinoma of the larynx: preliminary study |journal=Laryngoscope |volume=123 |issue=10 |pages=2485–90 |date=October 2013 |pmid=23918439 |doi=10.1002/lary.23994 |url=}}</ref> | ||
* Total [[laryngectomy]] | * Total [[laryngectomy]]<ref name="pmid2034244">{{cite journal |vauthors=Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE, Endicott JW, McClatchey K, Henderson WG |title=Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer |journal=N. Engl. J. Med. |volume=324 |issue=24 |pages=1685–90 |date=June 1991 |pmid=2034244 |doi=10.1056/NEJM199106133242402 |url=}}</ref> | ||
* Total [[laryngectomy]] with partial pharyngectomy | * Total [[laryngectomy]] with partial pharyngectomy <ref name="pmid22492697">{{cite journal |vauthors=Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L, de Raucourt D, Langendijk JA |title=Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891 |journal=Ann. Oncol. |volume=23 |issue=10 |pages=2708–14 |date=October 2012 |pmid=22492697 |doi=10.1093/annonc/mds065 |url=}}</ref><ref name="pmid8656441">{{cite journal |vauthors=Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T |title=Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group |journal=J. Natl. Cancer Inst. |volume=88 |issue=13 |pages=890–9 |date=July 1996 |pmid=8656441 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
Latest revision as of 00:46, 20 March 2019
|
Laryngeal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Laryngeal cancer surgery On the Web |
|
American Roentgen Ray Society Images of Laryngeal cancer surgery |
|
Risk calculators and risk factors for Laryngeal cancer surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
The feasibility of surgery depends on the stage of laryngeal cancer at the time of diagnosis. The goal of treatment is to completely remove the tumor, achieve tumor free margins and prevent the spread. The options of surgery can be transoral laser surgery, transoral robotic surgery, total laryngectomy, and total laryngectomy with partial pharyngectomy
Surgery
The goal of treatment is to completely remove the tumor, achieve tumor free margins and prevent the spread. The following options of surgery can be considered on a case by case basis:
- Transoral laser surgery [1][2]
- Transoral robotic surgery [3][4]
- Total laryngectomy[5]
- Total laryngectomy with partial pharyngectomy [6][7]
References
- ↑ Ambrosch P (April 2007). "The role of laser microsurgery in the treatment of laryngeal cancer". Curr Opin Otolaryngol Head Neck Surg. 15 (2): 82–8. doi:10.1097/MOO.0b013e3280147336. PMID 17413407.
- ↑ Zeitels SM, Burns JA (December 2014). "Oncologic efficacy of angiolytic KTP laser treatment of early glottic cancer". Ann. Otol. Rhinol. Laryngol. 123 (12): 840–6. doi:10.1177/0003489414538936. PMID 24970297.
- ↑ Mendelsohn AH, Remacle M, Van Der Vorst S, Bachy V, Lawson G (January 2013). "Outcomes following transoral robotic surgery: supraglottic laryngectomy". Laryngoscope. 123 (1): 208–14. doi:10.1002/lary.23621. PMID 23008093.
- ↑ Lallemant B, Chambon G, Garrel R, Kacha S, Rupp D, Galy-Bernadoy C, Chapuis H, Lallemant JG, Pham HT (October 2013). "Transoral robotic surgery for the treatment of T1-T2 carcinoma of the larynx: preliminary study". Laryngoscope. 123 (10): 2485–90. doi:10.1002/lary.23994. PMID 23918439.
- ↑ Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE, Endicott JW, McClatchey K, Henderson WG (June 1991). "Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer". N. Engl. J. Med. 324 (24): 1685–90. doi:10.1056/NEJM199106133242402. PMID 2034244.
- ↑ Lefebvre JL, Andry G, Chevalier D, Luboinski B, Collette L, Traissac L, de Raucourt D, Langendijk JA (October 2012). "Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891". Ann. Oncol. 23 (10): 2708–14. doi:10.1093/annonc/mds065. PMID 22492697.
- ↑ Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (July 1996). "Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group". J. Natl. Cancer Inst. 88 (13): 890–9. PMID 8656441.